{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:02:36Z","timestamp":1720382556614},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.leukres.2016.04.016","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T01:52:08Z","timestamp":1462067528000},"page":"101-106","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Increased Lipocalin 2 level may have important role in thrombotic events in patients with polycythemia vera and essential thrombocythemia"],"prefix":"10.1016","volume":"48","author":[{"given":"P.","family":"Rajnics","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9.","family":"Kar\u00e1di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Moizs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cs.","family":"B\u00f6d\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"Kir\u00e1ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Marosv\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Andrikovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Egyed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2016.04.016_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2004.06.032","article-title":"Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia","volume":"117","author":"Passamonti","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.leukres.2016.04.016_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00277-007-0386-3","article-title":"Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis","volume":"87","author":"Alvarez- Larran","year":"2008","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0015","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2009-02-206797","article-title":"Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?","volume":"114","author":"Barbui","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.016_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.leu.2404048","article-title":"Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution","volume":"20","author":"Cervantes","year":"2006","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2016.04.016_bib0025","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemia vera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2016.04.016_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"United Kingdom Medical Research Council primary thrombocythemia 1 study Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.leukres.2016.04.016_bib0035","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2016.04.016_bib0040","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2012-07-443770","article-title":"Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial","volume":"121","author":"Gisslinger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.016_bib0045","first-page":"238","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","author":"Barbui","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.016_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2006.06430.x","article-title":"The haematocrit and platelet target in polycythemia vera","volume":"136","author":"Di Nisio","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2141.2007.06674.x","article-title":"Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation","volume":"138","author":"Gangat","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0060","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2016.04.016_bib0065","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood-2006-10-048298","article-title":"Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu\/BCAM","volume":"110","author":"Wautier","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.016_bib0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3324\/haematol.13774","article-title":"Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia","volume":"94","author":"Trappenburg","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2016.04.016_bib0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2003-44552","article-title":"Hyperviscosity in polycythemia vera and other red cell abnormalities","volume":"29","author":"Kwaan","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.leukres.2016.04.016_bib0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","article-title":"Leukocyte- platelet interaction in patients with essential thrombocythemia and polycythemia vera","volume":"33","author":"Falanga","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1538-7836.2006.01968.x","article-title":"Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation","volume":"4","author":"Maugeri","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.leukres.2016.04.016_bib0090","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood-2008-06-164087","article-title":"Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera","volume":"112","author":"Marchetti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.016_bib0095","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1182\/blood-2006-08-042515","article-title":"Leukocytosis as a major thrombotic risk factor in patients with Polycythemia Vera","volume":"109","author":"Landolfi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.04.016_bib0100","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1200\/JCO.2007.15.3569","article-title":"Leukocytosis and risk stratification assessment in essential thrombocythemia","volume":"26","author":"Carobbio","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/095371000403134","article-title":"Increased leukocyteplatelet adhesion in chronic myeloproliferative disorders with high platelet counts","volume":"11","author":"Kaplar","year":"2000","journal-title":"Platelets"},{"key":"10.1016\/j.leukres.2016.04.016_bib0110","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1538-7836.2006.02194.x","article-title":"Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?","volume":"4","author":"Maugeri","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.leukres.2016.04.016_bib0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428194.2010.531413","article-title":"Increased serum levels of neutrophil gelatinaseassociated lipocalin in patients with essential thrombocythemia and polycythemia vera","volume":"52","author":"Allegra","year":"2011","journal-title":"Leuk. Lymphoma"},{"issue":"13","key":"10.1016\/j.leukres.2016.04.016_bib0120","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1182\/blood-2013-12-544197","article-title":"Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators. miRNAmRNA integrative analysis in primary myelofibrosis CD341 cells: role of miR- 155\/JARID2 axis in abnormal megakaryopoiesis","volume":"124","author":"Norfo","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.leukres.2016.04.016_bib0125","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2014-04-570572","article-title":"JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2","volume":"124","author":"Kagoya","year":"2014","journal-title":"Blood"},{"issue":"July","key":"10.1016\/j.leukres.2016.04.016_bib0130","article-title":"The revised World Health Organisation diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal","volume":"112","author":"Spivak","year":"2008","journal-title":"Blood"},{"issue":"June (4)","key":"10.1016\/j.leukres.2016.04.016_bib0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2007-976165","article-title":"Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F","volume":"33","author":"Tefferi","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.leukres.2016.04.016_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3180001","article-title":"The lipocalin protein family: structure and function","volume":"318","author":"Flower","year":"1996","journal-title":"J. Biochem."},{"key":"10.1016\/j.leukres.2016.04.016_bib0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-5793(93)80382-5","article-title":"Structural relationship of streptavidin to the calycin protein superfamily","volume":"333","author":"Flower","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.leukres.2016.04.016_bib0150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.1997.tb46237.x","article-title":"Development of neutrophil granule diversity","volume":"832","author":"Borregaard","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.leukres.2016.04.016_bib0155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake","volume":"123","author":"Devireddy","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2016.04.016_bib0160","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/er.2001-0026","article-title":"Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation","volume":"23","author":"Sepp\u00e4l\u00e4","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.leukres.2016.04.016_bib0165","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03104","article-title":"Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron","volume":"432","author":"Flo","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2016.04.016_bib0170","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1095\/biolreprod66.2.458","article-title":"Mammalian lipocalin-type prostaglandin D2 synthase in the fluids of the male genital tract: putative biochemical and physiological functions","volume":"66","author":"Fouch\u00e9court","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.leukres.2016.04.016_bib0175","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/eurheartj\/ehp088","article-title":"Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure","volume":"30","author":"Yndestad","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.leukres.2016.04.016_bib0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e31819d6139","article-title":"Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass","volume":"53","author":"Tuladhar","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj20020026","article-title":"High expression in involuting reproductive tissues of uterocalin\/24p3, a lipocalin and acute phase protein","volume":"367","author":"Ryon","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.leukres.2016.04.016_bib0190","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1210\/jc.2007-1755","article-title":"High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus","volume":"93","author":"Choi","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.leukres.2016.04.016_bib0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0167-4838(00)00163-1","article-title":"Lipocalins as biochemical markers of disease","volume":"1482","author":"Xu","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.leukres.2016.04.016_bib0200","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.2337\/db08-0866","article-title":"Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels","volume":"57","author":"Henze","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.leukres.2016.04.016_bib0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1155\/2009\/725948","article-title":"Retinol binding protein-4 is associated with TNF-alpha and not insulin resistance in subjects with type 2 diabetes mellitus and coronary heart disease","volume":"26","author":"Al- Daghri","year":"2009","journal-title":"Dis. Markers"},{"key":"10.1016\/j.leukres.2016.04.016_bib0210","first-page":"34","article-title":"Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans","volume":"53","author":"Wang","year":"2007","journal-title":"ClinChem"},{"key":"10.1016\/j.leukres.2016.04.016_bib0215","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1476-5381.2011.01587.x","article-title":"Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition","volume":"165","author":"Liu","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.leukres.2016.04.016_bib0220","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/01.HYP.0000148303.98066.ab","article-title":"Hypertension and RhoA\/Rho-kinase signaling in the vasculature: highlights from the recent literature","volume":"44","author":"Lee","year":"2004","journal-title":"Hypertension"},{"issue":"November (2)","key":"10.1016\/j.leukres.2016.04.016_bib0225","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1365-2141.2001.03092.x","article-title":"Endothelial dysfunction in patients with polycythaemia vera","volume":"115","author":"Neunteufl","year":"2001","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616300911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T05:23:13Z","timestamp":1600492993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616300911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"alternative-id":["S0145212616300911"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.04.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Lipocalin 2 level may have important role in thrombotic events in patients with polycythemia vera and essential thrombocythemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}